Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ying, J.
Right arrow Articles by Tao, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ying, J.
Right arrow Articles by Tao, Q.
Clinical Cancer Research Vol. 11, 6442-6449, September 15, 2005
© 2005 American Association for Cancer Research


Human Cancer Biology

The Stress-Responsive Gene GADD45G Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors

Jianming Ying1,2, Gopesh Srivastava3, Wen-Son Hsieh1,4, Zifen Gao5, Paul Murray6, Shuen-Kuei Liao7, Richard Ambinder4 and Qian Tao1,2,4

Authors' Affiliations: 1 Johns Hopkins Singapore, Singapore; 2 Cancer Epigenetics Laboratory, Department of Clinical Oncology, Sir YK Pao Cancer Center, Chinese University of Hong Kong; 3 Department of Pathology, University of Hong Kong, Hong Kong; 4 Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland; 5 Department of Pathology, Peking University Health Science Center, Beijing, China; 6 Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, United Kingdom; and 7 Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taiwan, China

Requests for reprints: Qian Tao, Department of Clinical Oncology, Sir YK Pao Cancer Center, Prince of Wales Hospital, Chinese University of Hong Kong, Room 315, Hong Kong. Phone: 852-2632-1340; Fax: 852-2648-8842; E-mail: qtao{at}clo.cuhk.edu.hk.

The CpG island of GADD45G was identified as a target sequence during the identification of hypermethylated genes using methylation-sensitive representational difference analysis combined with 5-aza-2'-deoxycytidine demethylation. Located at the commonly deleted region 9q22, GADD45G is a member of the DNA damage-inducible gene family. In response to stress shock, GADD45G inhibits cell growth and induces apoptosis. Same as other GADD45 members, GADD45G is ubiquitously expressed in all normal adult and fetal tissues. However, its transcriptional silencing or down-regulation and promoter hypermethylation were frequently detected in tumor cell lines, including 11 of 13 (85%) non-Hodgkin's lymphoma, 3 of 6 (50%) Hodgkin's lymphoma, 8 of 11 (73%) nasopharyngeal carcinoma, 2 of 4 (50%) cervical carcinoma, 5 of 17 (29%) esophageal carcinoma, and 2 of 5 (40%) lung carcinoma and other cell lines but not in any immortalized normal epithelial cell line, normal tissue, or peripheral blood mononuclear cells. The silencing of GADD45G could be reversed by 5-aza-2'-deoxycytidine or genetic double knockout of DNMT1 and DNMT3B, indicating a direct epigenetic mechanism. Aberrant methylation was further frequently detected in primary lymphomas although less frequently in primary carcinomas. Only one single sequence change in the coding region was detected in 1 of 25 cell lines examined, indicating that genetic inactivation of GADD45G is very rare. GADD45G could be induced by heat shock or UV irradiation in unmethylated cell lines; however, this stress response was abolished when its promoter becomes hypermethylated. Ectopic expression of GADD45G strongly suppressed tumor cell growth and colony formation in silenced cell lines. These results show that GADD45G can act as a functional new-age tumor suppressor but being frequently inactivated epigenetically in multiple tumors.




This article has been cited by other articles:


Home page
BloodHome page
A. Scuto, M. Kirschbaum, C. Kowolik, L. Kretzner, A. Juhasz, P. Atadja, V. Pullarkat, R. Bhatia, S. Forman, Y. Yen, et al.
The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells
Blood, May 15, 2008; 111(10): 5093 - 5100.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Schrag, S. Jiralerspong, M. Banville, M. L. Jaramillo, and M. D. O'Connor-McCourt
The crystal structure and dimerization interface of GADD45{gamma}
PNAS, May 6, 2008; 105(18): 6566 - 6571.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Ying, H. Li, J. Yu, K. M. Ng, F. F. Poon, S. C. C. Wong, A. T.C. Chan, J. J.Y. Sung, and Q. Tao
WNT5A Exhibits Tumor-Suppressive Activity through Antagonizing the Wnt/ -Catenin Signaling, and Is Frequently Methylated in Colorectal Cancer
Clin. Cancer Res., January 1, 2008; 14(1): 55 - 61.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Ying, H. Li, Y.-W. Chen, G. Srivastava, Z. Gao, and Q. Tao
WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor
Blood, December 1, 2007; 110(12): 4130 - 4131.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Shao, Y. Cui, H. Li, Y. Liu, H. Zhao, Y. Wang, Y. Zhang, K. M. Ng, W. Han, D. Ma, et al.
CMTM5 Exhibits Tumor Suppressor Activities and Is Frequently Silenced by Methylation in Carcinoma Cell Lines
Clin. Cancer Res., October 1, 2007; 13(19): 5756 - 5762.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Nakayama, N. Nakayama, T.-L. Wang, and I.-M. Shih
NAC-1 Controls Cell Growth and Survival by Repressing Transcription of Gadd45GIP1, a Candidate Tumor Suppressor
Cancer Res., September 1, 2007; 67(17): 8058 - 8064.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Jin, X. Wang, J. Ying, A. H. Y. Wong, Y. Cui, G. Srivastava, Z.-Y. Shen, E.-M. Li, Q. Zhang, J. Jin, et al.
Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers
PNAS, July 24, 2007; 104(30): 12353 - 12358.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. F. Zerbini and T. A. Libermann
GADD45 Deregulation in Cancer: Frequently Methylated Tumor Suppressors and Potential Therapeutic Targets
Clin. Cancer Res., September 15, 2005; 11(18): 6409 - 6413.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.